Black Rock Inc. Bridge Bio Pharma, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 12,448,272 shares of BBIO stock, worth $789 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,448,272
              Previous 10,466,935
              
        
           18.93%
        
      
          
        Holding current value
$789 Million
            Previous $324 Million
            
        
           2.57%
        
      
          
        % of portfolio
0.01%
            Previous 0.01%
          
        Shares
	  13 transactions
	
  Others Institutions Holding BBIO
# of Institutions
412Shares Held
187MCall Options Held
11.3MPut Options Held
1.93M- 
    
      Viking Global Investors LP18.6MShares$1.18 Billion2.54% of portfolio
- 
    
      Vanguard Group Inc Valley Forge, PA16.5MShares$1.04 Billion0.01% of portfolio
- 
    
      Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$840 Million22.63% of portfolio
- 
    
      Janus Henderson Group PLC London, X09.28MShares$588 Million0.21% of portfolio
- 
    
      Farallon Capital Management LLC San Francisco, CA7.9MShares$501 Million1.53% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.39B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...